Search

Search any products, services and so on here.

About 16311 result(s)

Global Tacrolimus Injection Market Research Report 2024

  • Jan 18, 24
  • ID: 3123
  • Pages: 73
  • Figures: 160
  • Views: 16
  • From $2,900

Tacrolimus injection should only be given under the supervision of a doctor who is experienced in treating people who have had an organ transplant and in prescribing medications that decrease the activity of the immune system. The global Tacrolimus Injection market was valued at US$ 254 million in 2023 and is anticipated to reach US$ 387.4 million by 2030, witnessing a CAGR of 6.2% during the for...


Global Estradiol & Norethindrone Acetate Drug Market Research Report 2024

  • Jan 18, 24
  • ID: 3124
  • Pages: 83
  • Figures: 173
  • Views: 18
  • From $2,900

Estradiol/Norethindrone Acetate drug is used after menopause to reduce moderate to severe hot flushes, treat moderate to severe menopausal changes in and around the vagina, and help reduce your chances of getting osteoporosis (thin weak bones). The global Estradiol & Norethindrone Acetate Drug market was valued at US$ 650 million in 2023 and is anticipated to reach US$ 974.7 million by 2030, witn...


Global Testosterone Gel Market Research Report 2024

  • Jan 18, 24
  • ID: 3125
  • Pages: 83
  • Figures: 183
  • Views: 22
  • From $2,900

Testosterone gel is used to treat adult males who have low or no testosterone due to certain medical conditions. The global Testosterone Gel market was valued at US$ 302 million in 2023 and is anticipated to reach US$ 480.1 million by 2030, witnessing a CAGR of 6.5% during the forecast period 2024-2030. North American market for Testosterone Gel is estimated to increase from $ million in 2023 to...


Global Transdermal Testosterone Market Research Report 2024

  • Jan 18, 24
  • ID: 3126
  • Pages: 91
  • Figures: 204
  • Views: 20
  • From $2,900

Transdermal Testosterone contains testosterone. It is used for hormone replacement in men who are not able to produce enough testosterone (e.g., hypogonadism). This medication is absorbed through the skin, enters your bloodstream, and helps your body reach normal testosterone levels. The global Transdermal Testosterone market was valued at US$ 589 million in 2023 and is anticipated to reach US$ 9...


Global Testosterone Undecanoate Market Research Report 2024

  • Jan 18, 24
  • ID: 3127
  • Pages: 86
  • Figures: 184
  • Views: 18
  • From $2,900

Testosterone undecanoate, sold under the brand names Nebido, Aveed, and Andriol among others, is an androgen and anabolic steroid (AAS) medication which is used mainly in the treatment of low testosterone levels in men. It is also used in hormone therapy for transgender men. It is taken by mouth two to three times per day with food or given by injection into muscle once every 12 weeks or so. The...


Global Testosterone Cypionate Market Research Report 2024

  • Jan 18, 24
  • ID: 3128
  • Pages: 79
  • Figures: 187
  • Views: 20
  • From $2,900

Testosterone cypionate, sold under the brand name Depo-Testosterone among others, is an androgen and anabolic steroid (AAS) medication which is used mainly in the treatment of low testosterone levels in men. It is also used in hormone therapy for transgender men. It is given by injection into muscle or subcutaneously, once every one to four weeks, depending on clinical indication. The global Test...


Global Methyltestosterone Market Research Report 2024

  • Jan 18, 24
  • ID: 3129
  • Pages: 75
  • Figures: 156
  • Views: 19
  • From $2,900

Methyltestosterone, sold under the brand names Android, Metandren, and Testred among others, is an androgen and anabolic steroid (AAS) medication which is used in the treatment of low testosterone levels in men, delayed puberty in boys, at low doses as a component of menopausal hormone therapy for menopausal symptoms like hot flashes, osteoporosis, and low sexual desire in women, and to treat brea...


Global Candesartan and Hydrochlorothiazide Market Research Report 2024

  • Jan 18, 24
  • ID: 3130
  • Pages: 84
  • Figures: 185
  • Views: 16
  • From $2,900

Candesartan and Hydrochlorothiazide contains 2 medications: candesartan and hydrochlorothiazide. Candesartan belongs to a family of medications known as angiotensin II receptor blockers. Hydrochlorothiazide belongs to a family of medications known as diuretics (or "water pills"). This combination medication is used to lower high blood pressure. The global Candesartan and Hydrochlorothiazide marke...


Global Bivalirudin Drug Market Research Report 2024

  • Jan 18, 24
  • ID: 3133
  • Pages: 78
  • Figures: 179
  • Views: 17
  • From $2,900

Bivalirudin (Angiomax or Angiox, manufactured by The Medicines Company) is a direct thrombin inhibitor (DTI). The global Bivalirudin Drug market was valued at US$ 596 million in 2023 and is anticipated to reach US$ 887.2 million by 2030, witnessing a CAGR of 6.5% during the forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the...


Global Candesartan Cilexetil Drug Market Research Report 2024

  • Jan 18, 24
  • ID: 3134
  • Pages: 86
  • Figures: 193
  • Views: 18
  • From $2,900

Candesartan Cilexetil is a prescription medicine for the treatment of heart failure and hypertension The global Candesartan Cilexetil Drug market was valued at US$ 548 million in 2023 and is anticipated to reach US$ 793.2 million by 2030, witnessing a CAGR of 6.1% during the forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during th...


Our team would be happy to assist you with your queries.

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232